{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T23:04:17Z","timestamp":1782255857696,"version":"3.54.5"},"reference-count":18,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","seizure-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seizure: European Journal of Epilepsy"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.seizure.2025.09.013","type":"journal-article","created":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T04:13:35Z","timestamp":1758773615000},"page":"161-166","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Fenfluramine treatment beyond dravet and lennox-gastaut syndromes - A retrospective study suggesting a novel use in genetic, developmental and epileptic encephalopathies (DEEs)"],"prefix":"10.1016","volume":"133","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-3650-5932","authenticated-orcid":false,"given":"Amy","family":"Urbina Lopez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0992-8476","authenticated-orcid":false,"given":"Robin T","family":"Varughese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Candice","family":"Marti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aizara","family":"Ermekbaeva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Poduri","family":"Annapurna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kothare","family":"Sanjeev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3695-0329","authenticated-orcid":false,"given":"Yash","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.seizure.2025.09.013_bib0001","article-title":"A review of fenfluramine for the treatment of Dravet syndrome patients","volume":"3","author":"Simon","year":"2021","journal-title":"Curr Res Pharmacol Drug Discov"},{"issue":"3","key":"10.1016\/j.seizure.2025.09.013_bib0002","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/0091-3057(88)90089-5","article-title":"Mechanisms of effects of D-Fenfluramine on brain serotonin metabolism in rats: uptake inhibition versus release","volume":"30","author":"Fuller","year":"1988","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.seizure.2025.09.013_bib0003","doi-asserted-by":"crossref","first-page":"191","DOI":"10.3389\/fphar.2017.00191","article-title":"Pharmacological Analysis of the Anti-Epileptic Mechanisms of Fenfluramine in Scn1a Mutant Zebrafish","volume":"8","author":"Sourbron","year":"2017","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.seizure.2025.09.013_bib0004","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/0922-4106(94)90102-3","article-title":"[3H](+)-Pentazocine Binding to Rat Brain Sigma 1 Receptors","volume":"266","author":"Cagnotto","year":"1994","journal-title":"Eur J Pharmacol"},{"issue":"8","key":"10.1016\/j.seizure.2025.09.013_bib0005","article-title":"Fenfluramine: A review of pharmacology, clinical efficacy, and safety in Epilepsy","volume":"9","author":"Samanta","year":"2022","journal-title":"Children (Basel, Switzerland)"},{"key":"10.1016\/j.seizure.2025.09.013_bib0006","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.yebeh.2018.08.021","article-title":"Individualized treatment approaches: fenfluramine, a novel antiepileptic medication for the treatment of seizures in Dravet syndrome","volume":"91","author":"Polster","year":"2019","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.seizure.2025.09.013_bib0007","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1001\/jamaneurol.2019.4113","article-title":"Fenfluramine for treatment-resistant seizures in patients with dravet syndrome receiving stiripentol-inclusive regimens: a randomized clinical trial","volume":"77","author":"Nabbout","year":"2020","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.seizure.2025.09.013_bib0008","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1016\/S0140-6736(19)32500-0","article-title":"Fenfluramine hydrochloride for the treatment of seizures in Dravet syndrome: a randomised, double-blind, placebo-controlled trial","volume":"394","author":"Lagae","year":"2019","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.seizure.2025.09.013_bib0009","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1001\/jamaneurol.2022.0829","article-title":"Efficacy and Safety of Fenfluramine for the Treatment of Seizures Associated With Lennox-Gastaut Syndrome: a Randomized Clinical Trial","volume":"79","author":"Knupp","year":"2022","journal-title":"JAMA Neurol"},{"issue":"4","key":"10.1016\/j.seizure.2025.09.013_bib0010","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1111\/epi.17521","volume":"64","author":"Faingold","year":"2023","journal-title":"Epilepsia"},{"issue":"5","key":"10.1016\/j.seizure.2025.09.013_bib0011","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1002\/epi4.13029","article-title":"Fenfluramine treatment in pediatric patients with Dravet syndrome reduces seizure burden and overall healthcare costs: a retrospective and observational real-world study","volume":"9","author":"Gjerulfsen","year":"2024","journal-title":"Epilepsia Open"},{"issue":"3","key":"10.1016\/j.seizure.2025.09.013_bib0012","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1002\/epi4.12623","article-title":"Effect of fenfluramine on seizures and comorbidities in SCN8A-developmental and epileptic encephalopathy: a case series","volume":"7","author":"Aledo-Serrano","year":"2022","journal-title":"Epilepsia Open"},{"key":"10.1016\/j.seizure.2025.09.013_bib0013","doi-asserted-by":"crossref","DOI":"10.1016\/j.yebeh.2020.106989","article-title":"Fenfluramine acts as a positive modulator of sigma-1 receptors","volume":"105","author":"Martin","year":"2020","journal-title":"Epilepsy Behav"},{"issue":"2","key":"10.1016\/j.seizure.2025.09.013_bib0014","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1007\/s40120-023-00452-1","article-title":"Efficacy and Safety of Fenfluramine in Epilepsy: a Systematic Review and Meta-analysis","volume":"12","author":"Tabaee Damavandi","year":"2023","journal-title":"Neurol Ther"},{"key":"10.1016\/j.seizure.2025.09.013_bib0015","article-title":"Successful use of Fenfluramine in super-refractory status epilepticus in a patient with tuberous sclerosis complex and Lennox-Gastaut syndrome","volume":"27","author":"Wildermann","year":"2024","journal-title":"Epilepsy Behav Rep"},{"issue":"34","key":"10.1016\/j.seizure.2025.09.013_bib0016","doi-asserted-by":"crossref","first-page":"23373","DOI":"10.18632\/oncotarget.25169","article-title":"Fenfluramine diminishes NMDA receptor-mediated seizures via its mixed activity at serotonin 5HT2A and type 1 sigma receptors","volume":"9","author":"Rodr\u00edguez-Mu\u00f1oz","year":"2018","journal-title":"Oncotarget"},{"issue":"9","key":"10.1016\/j.seizure.2025.09.013_bib0017","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.tips.2008.06.007","article-title":"Signaling at G-protein-coupled serotonin receptors: recent advances and future research directions","volume":"29","author":"Millan","year":"2008","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.seizure.2025.09.013_bib0018","series-title":"Handbook of Behavioral Neuroscience","first-page":"319","article-title":"5-HT neurons and central CO\u2082 chemoreception","volume":"31","author":"Teran","year":"2020"}],"container-title":["Seizure: European Journal of Epilepsy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1059131125002596?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1059131125002596?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,7]],"date-time":"2025-12-07T08:09:00Z","timestamp":1765094940000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1059131125002596"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":18,"alternative-id":["S1059131125002596"],"URL":"https:\/\/doi.org\/10.1016\/j.seizure.2025.09.013","relation":{},"ISSN":["1059-1311"],"issn-type":[{"value":"1059-1311","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fenfluramine treatment beyond dravet and lennox-gastaut syndromes - A retrospective study suggesting a novel use in genetic, developmental and epileptic encephalopathies (DEEs)","name":"articletitle","label":"Article Title"},{"value":"Seizure: European Journal of Epilepsy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.seizure.2025.09.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 British Epilepsy Association. Published by Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}